This site is intended for Healthcare Professionals only

Supervision rule changes

Supervision rule changes

For pharmacy owners, the important point is the reforms next month are not simply a relaxation of existing rules. Greater flexibility brings important questions about governance, competency and accountability, says Richard Hough… 

 

Community pharmacy is about to undergo one of the most significant changes for many years to the way dispensing responsibilities can be organised.

From December 10, 2026, the remaining provisions of the Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 come into force. The reforms are intended to make better use of pharmacy technicians’ skills and, importantly, enable pharmacists to spend more time providing patient-facing clinical services.

 

What is changing?

The new regulatory framework allows a pharmacist to authorise a registered pharmacy technician to carry out, or supervise others carrying out, activities relating to the preparation, assembly and dispensing of medicines and certain sales and supplies which would otherwise have to be carried out by, or under the supervision of, a pharmacist.

This follows an earlier change, effective from January this year, which allows a pharmacist to authorise appropriately trained pharmacy staff to hand out previously checked and bagged prescriptions during the pharmacist's absence. The direction of travel is clear. Pharmacists are increasingly being expected to operate as clinicians rather than having their time predominantly tied to the physical dispensing process.

That becomes particularly important following the introduction of independent prescribing into the Community Pharmacy Contractual Framework on October 29, 2026. Pharmacist prescribers can now prescribe within Pharmacy First and the pharmacy contraception service and through five additional prescribing-only Pharmacy First pathways.

The supervision reforms and prescribing reforms, therefore, need to be viewed together with the former potentially creating the capacity required to deliver the latter.

 

What is not changing?

As ever, there are several important caveats. Firstly, the reforms are enabling rather than compulsory. Pharmacists will not be required to authorise pharmacy technicians to undertake these activities.

Whether it is appropriate to do so will depend on the particular pharmacy, the individuals involved and their competence to undertake the activities being authorised. 

Secondly, the changes do not remove the requirement for a responsible pharmacist (RP) to be in place for each pharmacy. Nor does authorisation simply transfer all responsibility from the pharmacist to the technician.

The General Pharmaceutical Council (GPhC) has made clear that, where authorisation takes place, both the pharmacist giving the authorisation and the person receiving it have responsibilities in relation to the activities undertaken. 

 

The governance question

The reforms coincide with a wider overhaul of pharmacy governance. The GPhC has been developing new standards for RPs and superintendent pharmacists (SI), together with revised RP rules.

Its Council agreed the overall approach in October, although it requested further clarification concerning contingency arrangements where a SI is not in post.

The regulator has indicated that it plans to publish the approved standards by December 10, while the new RP rules are separately subject to the parliamentary process.

For owners, particularly those operating groups of pharmacies, this makes clarity of responsibility extremely important. The functions of the pharmacy owner, SI, RP, authorising pharmacist and authorised pharmacy technician are related, but they are not interchangeable.

Policies developed for the new regime should therefore avoid simply stating that a particular function is "delegated to the pharmacy technician".

They need to address who may authorise whom, what may be authorised, the limits of that authority and how competence will be assessed and monitored.

 

What should owners be doing now?

Before adopting the new freedoms, pharmacy businesses should consider at least five practical steps:

  • Firstly, identify appropriate pharmacy technicians. Registration alone should not automatically be regarded as demonstrating competence for every activity that could potentially be authorised.
  • Secondly, review standard operating procedures (SOPs). Existing SOPs may have been drafted around the old supervision model and should be checked against the new legislation, regulatory standards and professional guidance.
  • Thirdly, document authorisation clearly. Owners should consider how its scope, duration and any limitations will be recorded, together with arrangements for reviewing or withdrawing it.
  • Fourthly, consider liability and insurance. Employment contracts, locum arrangements and professional and corporate indemnity insurance should be checked to ensure that they reflect the way responsibilities are actually being allocated.
  • Finally, maintain effective escalation arrangements. A technician who is authorised to undertake an activity must be made aware of when something falls outside their competence or the scope of their authority and needs to be referred back to the pharmacist.

 

Opportunity, rather than simply deregulation

Handled properly, the reforms represent a substantial opportunity.

Releasing pharmacists from appropriate elements of the dispensing process should allow more of their time to be devoted to Pharmacy First, independent prescribing and other clinical services. That is increasingly important as community pharmacy continues its evolution from a predominantly dispensing-based model towards a broader clinical role.

But owners should resist treating 10 December as simply an opportunity to redistribute workload. The real opportunity is to redesign the pharmacy team, making better use of pharmacy technicians while putting sufficiently robust governance around that new model.

Those businesses which achieve that balance are likely to be best placed to benefit from the increasingly clinical role that community pharmacy is being asked to perform.

 

Richard Hough is a partner and head of healthcare at Brabners and a former pharmacist.

Share:

Change privacy settings